Eos Management L.P. maintained its position in shares of Walgreens Boots Alliance Inc. (NASDAQ:WBA) during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 9,143 shares of the pharmacy operator’s stock at the end of the second quarter. Walgreens Boots Alliance comprises about 1.5% of Eos Management L.P.’s investment portfolio, making the stock its 16th largest position. Eos Management L.P.’s holdings in Walgreens Boots Alliance were worth $761,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently made changes to their positions in the stock. Samlyn Capital LLC bought a new position in Walgreens Boots Alliance during the first quarter valued at about $75,200,000. Renaissance Technologies LLC raised its position in Walgreens Boots Alliance by 21.5% in the first quarter. Renaissance Technologies LLC now owns 648,000 shares of the pharmacy operator’s stock valued at $54,588,000 after buying an additional 114,800 shares during the period. Nisa Investment Advisors LLC raised its position in Walgreens Boots Alliance by 2.5% in the second quarter. Nisa Investment Advisors LLC now owns 304,710 shares of the pharmacy operator’s stock valued at $25,373,000 after buying an additional 7,325 shares during the period. LPL Financial LLC raised its position in Walgreens Boots Alliance by 9.2% in the first quarter. LPL Financial LLC now owns 598,159 shares of the pharmacy operator’s stock valued at $49,863,000 after buying an additional 50,306 shares during the period. Finally, AMP Capital Investors Ltd raised its position in Walgreens Boots Alliance by 14.7% in the first quarter. AMP Capital Investors Ltd now owns 340,366 shares of the pharmacy operator’s stock valued at $28,464,000 after buying an additional 43,644 shares during the period. Hedge funds and other institutional investors own 59.75% of the company’s stock.

Shares of Walgreens Boots Alliance Inc. (NASDAQ:WBA) opened at 81.49 on Friday. Walgreens Boots Alliance Inc. has a 12-month low of $71.50 and a 12-month high of $95.74. The firm has a market cap of $88.20 billion, a P/E ratio of 28.16 and a beta of 1.01. The company’s 50 day moving average price is $81.49 and its 200-day moving average price is $81.22.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Wednesday, July 6th. The pharmacy operator reported $1.18 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.14 by $0.04. Walgreens Boots Alliance had a return on equity of 15.56% and a net margin of 2.70%. The company had revenue of $29.50 billion for the quarter. During the same quarter last year, the company earned $1.02 EPS. Walgreens Boots Alliance’s revenue for the quarter was up 2.4% compared to the same quarter last year. On average, equities research analysts anticipate that Walgreens Boots Alliance Inc. will post $4.51 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Monday, September 12th. Shareholders of record on Friday, August 19th were issued a dividend of $0.375 per share. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.36. The ex-dividend date of this dividend was Wednesday, August 17th. This represents a $1.50 annualized dividend and a yield of 1.84%. Walgreens Boots Alliance’s dividend payout ratio is 51.90%.

Several research firms have issued reports on WBA. Robert W. Baird reiterated an “outperform” rating and issued a $95.00 target price on shares of Walgreens Boots Alliance in a research note on Saturday, September 10th. Deutsche Bank AG reiterated a “buy” rating and issued a $94.00 target price on shares of Walgreens Boots Alliance in a research note on Friday, September 9th. Credit Suisse Group AG reiterated an “outperform” rating and issued a $95.00 target price (up previously from $80.71) on shares of Walgreens Boots Alliance in a research note on Thursday, September 1st. Bank of America Corp. reiterated a “buy” rating and issued a $94.00 target price on shares of Walgreens Boots Alliance in a research note on Tuesday, August 30th. Finally, Leerink Swann reiterated an “outperform” rating on shares of Walgreens Boots Alliance in a research note on Tuesday, August 30th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $93.13.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,067 shares of the company’s stock in a transaction dated Tuesday, July 26th. The stock was sold at an average price of $81.35, for a total transaction of $168,150.45. Following the sale, the director now owns 26,690 shares in the company, valued at approximately $2,171,231.50. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Kathleen Wilson-Thompson sold 29,695 shares of the company’s stock in a transaction dated Thursday, July 14th. The stock was sold at an average price of $83.00, for a total value of $2,464,685.00. The disclosure for this sale can be found here. Company insiders own 21.10% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

5 Day Chart for NASDAQ:WBA

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc. (NASDAQ:WBA).

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.